Prevention of type 2 diabetes in obese at-risk subjects: a systematic review and meta-analysis

Claudia Merlotti, Alberto Morabito, Valerio Ceriani, Antonio E. Pontiroli

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Different intervention strategies can prevent new cases of type 2 diabetes (T2DM) in obese subjects. The present systematic review and meta-analysis evaluates the effectiveness of different strategies in prevention of type 2 diabetes in obese subjects. Studies were grouped into five different strategies: (1) physical activity ± diet; (2) anti-diabetic drugs (glitazones, metformin, glinides, alfa-glucosidase inhibitors); (3) antihypertensive drugs (ACE inhibitors, ARB); (4) weight loss-promoting drugs and lipid-lowering drugs (orlistat, bezafibrate, phentermine/topiramate controlled release); and (5) bariatric surgery. Only controlled studies, dealing with subjects BMI ≥ 30 kg/m2, were included in the analysis, whether randomized or non-randomized studies. Appropriate methodology (PRISMA statement) was adhered to. Publication bias was formally assessed. Eighteen studies (43,669 subjects, 30,774 with impaired glucose tolerance and/or impaired fasting glucose), published in English language as full papers, were analyzed to identify predictors of new cases of T2DM and were included in a meta-analysis (random-effects model) to study the effect of different strategies. Intervention effect (new cases of diabetes) was expressed as odds ratio (OR), with 95 % confidence intervals (CIs). In obese subjects, non-surgical strategies were able to prevent T2DM, with different effectiveness [OR from 0.44 (0.36–0.52) to 0.86 (0.80–0.92)]; in morbidly obese subjects, bariatric surgery was highly effective [OR = 0.10 (0.02–0.49)]. At meta-regression analysis, factors associated with effectiveness were weight loss, young age and fasting insulin levels. Publication bias was present only when considering all studies together. These data indicate that several strategies, with different effectiveness, can prevent T2DM in obese subjects.

Original languageEnglish
Pages (from-to)853-863
Number of pages11
JournalActa Diabetologica
Volume51
Issue number5
DOIs
Publication statusPublished - Sep 27 2014

Fingerprint

Type 2 Diabetes Mellitus
Meta-Analysis
Publication Bias
Bariatric Surgery
Odds Ratio
Fasting
Phentermine
Bezafibrate
Anti-Obesity Agents
Thiazolidinediones
Glucose Intolerance
Metformin
Angiotensin-Converting Enzyme Inhibitors
Pharmaceutical Preparations
Antihypertensive Agents
Weight Loss
Language
Regression Analysis
Confidence Intervals
Insulin

Keywords

  • Anti-diabetic drugs
  • Bariatric surgery
  • Lifestyle modifications
  • Meta-analysis
  • Obesity
  • Prevention
  • Type 2 diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Prevention of type 2 diabetes in obese at-risk subjects : a systematic review and meta-analysis. / Merlotti, Claudia; Morabito, Alberto; Ceriani, Valerio; Pontiroli, Antonio E.

In: Acta Diabetologica, Vol. 51, No. 5, 27.09.2014, p. 853-863.

Research output: Contribution to journalArticle

@article{46c1943520c84b78996d687e4f2ca566,
title = "Prevention of type 2 diabetes in obese at-risk subjects: a systematic review and meta-analysis",
abstract = "Different intervention strategies can prevent new cases of type 2 diabetes (T2DM) in obese subjects. The present systematic review and meta-analysis evaluates the effectiveness of different strategies in prevention of type 2 diabetes in obese subjects. Studies were grouped into five different strategies: (1) physical activity ± diet; (2) anti-diabetic drugs (glitazones, metformin, glinides, alfa-glucosidase inhibitors); (3) antihypertensive drugs (ACE inhibitors, ARB); (4) weight loss-promoting drugs and lipid-lowering drugs (orlistat, bezafibrate, phentermine/topiramate controlled release); and (5) bariatric surgery. Only controlled studies, dealing with subjects BMI ≥ 30 kg/m2, were included in the analysis, whether randomized or non-randomized studies. Appropriate methodology (PRISMA statement) was adhered to. Publication bias was formally assessed. Eighteen studies (43,669 subjects, 30,774 with impaired glucose tolerance and/or impaired fasting glucose), published in English language as full papers, were analyzed to identify predictors of new cases of T2DM and were included in a meta-analysis (random-effects model) to study the effect of different strategies. Intervention effect (new cases of diabetes) was expressed as odds ratio (OR), with 95 {\%} confidence intervals (CIs). In obese subjects, non-surgical strategies were able to prevent T2DM, with different effectiveness [OR from 0.44 (0.36–0.52) to 0.86 (0.80–0.92)]; in morbidly obese subjects, bariatric surgery was highly effective [OR = 0.10 (0.02–0.49)]. At meta-regression analysis, factors associated with effectiveness were weight loss, young age and fasting insulin levels. Publication bias was present only when considering all studies together. These data indicate that several strategies, with different effectiveness, can prevent T2DM in obese subjects.",
keywords = "Anti-diabetic drugs, Bariatric surgery, Lifestyle modifications, Meta-analysis, Obesity, Prevention, Type 2 diabetes",
author = "Claudia Merlotti and Alberto Morabito and Valerio Ceriani and Pontiroli, {Antonio E.}",
year = "2014",
month = "9",
day = "27",
doi = "10.1007/s00592-014-0624-9",
language = "English",
volume = "51",
pages = "853--863",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Springer-Verlag Italia s.r.l.",
number = "5",

}

TY - JOUR

T1 - Prevention of type 2 diabetes in obese at-risk subjects

T2 - a systematic review and meta-analysis

AU - Merlotti, Claudia

AU - Morabito, Alberto

AU - Ceriani, Valerio

AU - Pontiroli, Antonio E.

PY - 2014/9/27

Y1 - 2014/9/27

N2 - Different intervention strategies can prevent new cases of type 2 diabetes (T2DM) in obese subjects. The present systematic review and meta-analysis evaluates the effectiveness of different strategies in prevention of type 2 diabetes in obese subjects. Studies were grouped into five different strategies: (1) physical activity ± diet; (2) anti-diabetic drugs (glitazones, metformin, glinides, alfa-glucosidase inhibitors); (3) antihypertensive drugs (ACE inhibitors, ARB); (4) weight loss-promoting drugs and lipid-lowering drugs (orlistat, bezafibrate, phentermine/topiramate controlled release); and (5) bariatric surgery. Only controlled studies, dealing with subjects BMI ≥ 30 kg/m2, were included in the analysis, whether randomized or non-randomized studies. Appropriate methodology (PRISMA statement) was adhered to. Publication bias was formally assessed. Eighteen studies (43,669 subjects, 30,774 with impaired glucose tolerance and/or impaired fasting glucose), published in English language as full papers, were analyzed to identify predictors of new cases of T2DM and were included in a meta-analysis (random-effects model) to study the effect of different strategies. Intervention effect (new cases of diabetes) was expressed as odds ratio (OR), with 95 % confidence intervals (CIs). In obese subjects, non-surgical strategies were able to prevent T2DM, with different effectiveness [OR from 0.44 (0.36–0.52) to 0.86 (0.80–0.92)]; in morbidly obese subjects, bariatric surgery was highly effective [OR = 0.10 (0.02–0.49)]. At meta-regression analysis, factors associated with effectiveness were weight loss, young age and fasting insulin levels. Publication bias was present only when considering all studies together. These data indicate that several strategies, with different effectiveness, can prevent T2DM in obese subjects.

AB - Different intervention strategies can prevent new cases of type 2 diabetes (T2DM) in obese subjects. The present systematic review and meta-analysis evaluates the effectiveness of different strategies in prevention of type 2 diabetes in obese subjects. Studies were grouped into five different strategies: (1) physical activity ± diet; (2) anti-diabetic drugs (glitazones, metformin, glinides, alfa-glucosidase inhibitors); (3) antihypertensive drugs (ACE inhibitors, ARB); (4) weight loss-promoting drugs and lipid-lowering drugs (orlistat, bezafibrate, phentermine/topiramate controlled release); and (5) bariatric surgery. Only controlled studies, dealing with subjects BMI ≥ 30 kg/m2, were included in the analysis, whether randomized or non-randomized studies. Appropriate methodology (PRISMA statement) was adhered to. Publication bias was formally assessed. Eighteen studies (43,669 subjects, 30,774 with impaired glucose tolerance and/or impaired fasting glucose), published in English language as full papers, were analyzed to identify predictors of new cases of T2DM and were included in a meta-analysis (random-effects model) to study the effect of different strategies. Intervention effect (new cases of diabetes) was expressed as odds ratio (OR), with 95 % confidence intervals (CIs). In obese subjects, non-surgical strategies were able to prevent T2DM, with different effectiveness [OR from 0.44 (0.36–0.52) to 0.86 (0.80–0.92)]; in morbidly obese subjects, bariatric surgery was highly effective [OR = 0.10 (0.02–0.49)]. At meta-regression analysis, factors associated with effectiveness were weight loss, young age and fasting insulin levels. Publication bias was present only when considering all studies together. These data indicate that several strategies, with different effectiveness, can prevent T2DM in obese subjects.

KW - Anti-diabetic drugs

KW - Bariatric surgery

KW - Lifestyle modifications

KW - Meta-analysis

KW - Obesity

KW - Prevention

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84919487349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919487349&partnerID=8YFLogxK

U2 - 10.1007/s00592-014-0624-9

DO - 10.1007/s00592-014-0624-9

M3 - Article

C2 - 25085464

AN - SCOPUS:84919487349

VL - 51

SP - 853

EP - 863

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

IS - 5

ER -